9. De gecompliceerde zwangerschap en complicaties die door de zwangerschap worden veroorzaakt

go back to reference Van Oppenraaij RHF, Goddijn M, Lok CAR, Exalto N. De jonge zwangerschap: revisie van de Nederlandse benamingen voor klinische en echoscopische bevindingen. Ned Tijdschr Geneeskd. 2008;152:20–4.PubMed Van Oppenraaij RHF, Goddijn M, Lok CAR, Exalto N. De jonge zwangerschap: revisie van de Nederlandse benamingen voor klinische en echoscopische bevindingen. Ned Tijdschr Geneeskd. 2008;152:20–4.PubMed

go back to reference Goddijn M, Van den Boogaard E, Steegers EAP, Erwich JJHM, Macklon NS, Land JA, Ankum WM. Richtlijn Herhaalde miskraam (eerste herziening) van de Nederlandse Vereniging voor Obstetrie en Gynaecologie. Ned Tijdschr Geneeskd. 2008;152:1665–70. Goddijn M, Van den Boogaard E, Steegers EAP, Erwich JJHM, Macklon NS, Land JA, Ankum WM. Richtlijn Herhaalde miskraam (eerste herziening) van de Nederlandse Vereniging voor Obstetrie en Gynaecologie. Ned Tijdschr Geneeskd. 2008;152:1665–70.

go back to reference Robinson GE. Pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2014;28:169–78.CrossRef Robinson GE. Pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2014;28:169–78.CrossRef

go back to reference Stirrat. Recurrent miscarriage I: definition and epidemiology. Lancet. 1990;336:673–5.CrossRef Stirrat. Recurrent miscarriage I: definition and epidemiology. Lancet. 1990;336:673–5.CrossRef

go back to reference Cole LA. The hCG assay or pregnancy test. Clin Chem Lab Med. 2012;50:617–30.CrossRef Cole LA. The hCG assay or pregnancy test. Clin Chem Lab Med. 2012;50:617–30.CrossRef

go back to reference Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29:507–13.CrossRef Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29:507–13.CrossRef

go back to reference www.nhg.org/standaarden/samenvatting/miskraam. www.​nhg.​org/​standaarden/​samenvatting/​miskraam.

go back to reference Lemmers M, Verschoor MAC, Bossuyt PM, Huirne JAF, Spinder T, Nieboer TE, et al.; for the MisoREST study group. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study. Acta Obstet Gynecol Scand. 2018;97:294–300.CrossRef Lemmers M, Verschoor MAC, Bossuyt PM, Huirne JAF, Spinder T, Nieboer TE, et al.; for the MisoREST study group. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study. Acta Obstet Gynecol Scand. 2018;97:294–300.CrossRef

go back to reference Verschoor MAC, Lemmers M, Wekker MZ, Ankum WM, Mol BWJ, Goddijn M. Behandelopties voor vroege miskramen. Ned Tijdschr Geneesk. 2014;158:A7900. Verschoor MAC, Lemmers M, Wekker MZ, Ankum WM, Mol BWJ, Goddijn M. Behandelopties voor vroege miskramen. Ned Tijdschr Geneesk. 2014;158:A7900.

go back to reference Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017;(1):CD007223. Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017;(1):CD007223.

go back to reference Lédée N, Prat-Ellenberg L, Petitbarat M, Chevrier L, Simon C, Irani EE, Vitoux D, et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J Reprod Immunol. 2018;127:11–5.CrossRef Lédée N, Prat-Ellenberg L, Petitbarat M, Chevrier L, Simon C, Irani EE, Vitoux D, et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J Reprod Immunol. 2018;127:11–5.CrossRef

go back to reference Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996;334:567–72.CrossRef Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996;334:567–72.CrossRef

go back to reference Drassinower D, Obican SG, Siddiq Z, Heller D, Gyamfi-Bannerman C, Friedman AM. Does the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy? Am J Obstet Gynecol. 2015;213(686):e1–7. Drassinower D, Obican SG, Siddiq Z, Heller D, Gyamfi-Bannerman C, Friedman AM. Does the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy? Am J Obstet Gynecol. 2015;213(686):e1–7.

go back to reference Phillips C, Velji Z, Hanly C, Metcalfe A. Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis. BMJ Open. 2017;7:e015402.CrossRef Phillips C, Velji Z, Hanly C, Metcalfe A. Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis. BMJ Open. 2017;7:e015402.CrossRef

go back to reference Bloom SL, et al. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98:379–85.PubMed Bloom SL, et al. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98:379–85.PubMed

go back to reference Kazemier BM, Buijs PE, Mignini L, Limpens J, De Groot CJ, Mol BW; EBM CONNECT. Impact of obstetric history on the risk of spontaneous preterm birth in singleton and multiple pregnancies: a systematic review. BJOG. 2014;121:1197–208. Kazemier BM, Buijs PE, Mignini L, Limpens J, De Groot CJ, Mol BW; EBM CONNECT. Impact of obstetric history on the risk of spontaneous preterm birth in singleton and multiple pregnancies: a systematic review. BJOG. 2014;121:1197–208.

go back to reference Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633. Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633.

go back to reference Garcia ER, Yim IS. A systematic review of concepts related to women’s empowerment in the perinatal period and their associations with perinatal depressive symptoms and premature birth. BMC Pregnancy Childbirth. 2017;17:347.CrossRef Garcia ER, Yim IS. A systematic review of concepts related to women’s empowerment in the perinatal period and their associations with perinatal depressive symptoms and premature birth. BMC Pregnancy Childbirth. 2017;17:347.CrossRef

go back to reference Palmer KT, Bonzini M, Harris EC, Linaker C, Bonde JP. Work activities and risk of prematurity, low birth weight and pre-eclampsia: an updated review with meta-analysis. Occup Environ Med. 2013;70:213–22.CrossRef Palmer KT, Bonzini M, Harris EC, Linaker C, Bonde JP. Work activities and risk of prematurity, low birth weight and pre-eclampsia: an updated review with meta-analysis. Occup Environ Med. 2013;70:213–22.CrossRef

go back to reference Brown RG, Marchesi JR, Lee YS, Smith A, Lehne B, Kindinger LM, Terzidou V, et al. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin. BMC Med. 2018;16:9. Brown RG, Marchesi JR, Lee YS, Smith A, Lehne B, Kindinger LM, Terzidou V, et al. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin. BMC Med. 2018;16:9.

go back to reference Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;(3):CD004454. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;(3):CD004454.

go back to reference Althuisius S, Dekker G. Controversies regarding cervixal incompetence, short cervix, and the need for cerclage. Clin Perinatol. 2004;31:695–720.CrossRef Althuisius S, Dekker G. Controversies regarding cervixal incompetence, short cervix, and the need for cerclage. Clin Perinatol. 2004;31:695–720.CrossRef

go back to reference Kindinger LM, Kyrgiou M, MacIntyre DA, Cacciatore S, Yulia A, Cook J, Terzidou V, et al. Preterm birth prevention post-conization: a model of cervical length screening with targeted cerclage. PLoS ONE. 2016;11:e0163793.CrossRef Kindinger LM, Kyrgiou M, MacIntyre DA, Cacciatore S, Yulia A, Cook J, Terzidou V, et al. Preterm birth prevention post-conization: a model of cervical length screening with targeted cerclage. PLoS ONE. 2016;11:e0163793.CrossRef

go back to reference Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev. 2013:CD007873. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev. 2013:CD007873.

go back to reference Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Shou Hammerum M, Mohapeloa H, Tabor A. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand. 2009;88:1180–9.CrossRef Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Shou Hammerum M, Mohapeloa H, Tabor A. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand. 2009;88:1180–9.CrossRef

go back to reference Sotiriadis A, Papatheodorou S, Makrydimas G. Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis. Ultrasound Obstet Gynecol. 2012;40:257–66.CrossRef Sotiriadis A, Papatheodorou S, Makrydimas G. Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis. Ultrasound Obstet Gynecol. 2012;40:257–66.CrossRef

go back to reference Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013;1:CD000262. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013;1:CD000262.

go back to reference McKinlay CJ, Crowther CA, Middleton P, Harding JE. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am J Obstet Gynecol. 2012;206:187–94.CrossRef McKinlay CJ, Crowther CA, Middleton P, Harding JE. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am J Obstet Gynecol. 2012;206:187–94.CrossRef

go back to reference Kenyon SL, Taylor DJ, Tarnow-Mordi W; for the ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetalmembranes: the ORACLE I randomised trial. Lancet. 2001;357:979–88. Kenyon SL, Taylor DJ, Tarnow-Mordi W; for the ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetalmembranes: the ORACLE I randomised trial. Lancet. 2001;357:979–88.

go back to reference Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013;(12):CD001058. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013;(12):CD001058.

go back to reference Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372:1319–27.CrossRef Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372:1319–27.CrossRef

go back to reference Crowther CA, Middleton PF, Voysey M, Askie L, Duley L, Pryde PG, Marret S, Doyle LE; for the AMICABLE Group. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis. PLoS Med. 2017;14:e1002398.CrossRef Crowther CA, Middleton PF, Voysey M, Askie L, Duley L, Pryde PG, Marret S, Doyle LE; for the AMICABLE Group. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis. PLoS Med. 2017;14:e1002398.CrossRef

go back to reference Bergenhenegouwen LA, Meertens LJ, Schaaf J, Nijhuis JG, Mol BW, Kok M, Scheepers HC. Vaginal delivery versus caesarean section in preterm breech delivery: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2014;172:1–6.CrossRef Bergenhenegouwen LA, Meertens LJ, Schaaf J, Nijhuis JG, Mol BW, Kok M, Scheepers HC. Vaginal delivery versus caesarean section in preterm breech delivery: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2014;172:1–6.CrossRef

go back to reference Hutchon D. Evolution of neonatal resuscitation with intact placental circulation. Infant. 2014;10:58–61. Hutchon D. Evolution of neonatal resuscitation with intact placental circulation. Infant. 2014;10:58–61.

go back to reference Källén K, Serenius F, Westgren M, Maršál K; for the EXPRESS Group. Impact of obstetric factors on outcome of extremely preterm births in Sweden: prospective population-based observational study (EXPRESS). Acta Obstet Gynecol Scand. 2015;94:1203–14.CrossRef Källén K, Serenius F, Westgren M, Maršál K; for the EXPRESS Group. Impact of obstetric factors on outcome of extremely preterm births in Sweden: prospective population-based observational study (EXPRESS). Acta Obstet Gynecol Scand. 2015;94:1203–14.CrossRef

go back to reference Serenius F, Källén K, Blennow M, Ewald U, Fellman V, Holmström G, Lindberg E, et al.; for the EXPRESS Group. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA. 2013;309:1810–20.CrossRef Serenius F, Källén K, Blennow M, Ewald U, Fellman V, Holmström G, Lindberg E, et al.; for the EXPRESS Group. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA. 2013;309:1810–20.CrossRef

go back to reference Walther FJ, et al. Looking back in time: outcome of a national cohort of very preterm infants born in the Netherlands in 1983. Early Hum Dev. 2000;59:175–91.CrossRef Walther FJ, et al. Looking back in time: outcome of a national cohort of very preterm infants born in the Netherlands in 1983. Early Hum Dev. 2000;59:175–91.CrossRef

go back to reference Thekkeveedu RK, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–7.CrossRef Thekkeveedu RK, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–7.CrossRef

go back to reference Aarnoudse-Moens CSH, Rijken M, Swarte RM, Andriessen P, Ter Horst HJ, Mulder-de Tollenaer SM, Koopman-Esseboom C, et al. Follow-up na 2 jaar van kinderen geboren bij 24 weken. Ned Tijdschr Geneeskd. 2017;161:D1168. Aarnoudse-Moens CSH, Rijken M, Swarte RM, Andriessen P, Ter Horst HJ, Mulder-de Tollenaer SM, Koopman-Esseboom C, et al. Follow-up na 2 jaar van kinderen geboren bij 24 weken. Ned Tijdschr Geneeskd. 2017;161:D1168.

go back to reference Feldman R, Rosenthal Z, Eidelman AI. Maternal-preterm skin-to-skin contact enhances child physiologic organization and cognitive control across the first 10 years of life. Biol Psychiatry. 2014;75:56–64.CrossRef Feldman R, Rosenthal Z, Eidelman AI. Maternal-preterm skin-to-skin contact enhances child physiologic organization and cognitive control across the first 10 years of life. Biol Psychiatry. 2014;75:56–64.CrossRef

go back to reference De Miranda E, Van der Bom JG, Bonsel GJ, Bleker OP, Rosendaal FR. Membrane sweeping and prevention of post-term pregnancy in low-risk pregnancies: a randomised controlled trial. BJOG. 2006;113:402–8.CrossRef De Miranda E, Van der Bom JG, Bonsel GJ, Bleker OP, Rosendaal FR. Membrane sweeping and prevention of post-term pregnancy in low-risk pregnancies: a randomised controlled trial. BJOG. 2006;113:402–8.CrossRef

go back to reference Gulmezoglu AM, Crowther CA, Middleton P, Heatly E. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2012;6:CD004945. Gulmezoglu AM, Crowther CA, Middleton P, Heatly E. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2012;6:CD004945.

go back to reference Koot MH, Boelig RC, Van ’t Hooft J, Limpens J, Roseboom TJ, Painter RC, Grooten IJ. Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review. BJOG. 2018. https://doi.org/10.1111/1471-0528.15272.CrossRef Koot MH, Boelig RC, Van ’t Hooft J, Limpens J, Roseboom TJ, Painter RC, Grooten IJ. Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review. BJOG. 2018. https://​doi.​org/​10.​1111/​1471-0528.​15272.CrossRef

go back to reference Malek NZH, Kalok A, Hanafiah ZA, Shah SA, Ismail NAM. Association of transient hyperthyroidism and severity of hyperemesis gravidarum. Horm Mol Biol Clin Investig. 2017;30(3). Malek NZH, Kalok A, Hanafiah ZA, Shah SA, Ismail NAM. Association of transient hyperthyroidism and severity of hyperemesis gravidarum. Horm Mol Biol Clin Investig. 2017;30(3).

go back to reference Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev. 2016:CD010607. Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev. 2016:CD010607.

go back to reference Vest AR, Cho LS. Hypertension in pregnancy. Curr Atheroscler Rep. 2014;16:395.CrossRef Vest AR, Cho LS. Hypertension in pregnancy. Curr Atheroscler Rep. 2014;16:395.CrossRef

go back to reference Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63:346–52.CrossRef Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63:346–52.CrossRef

go back to reference Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22.CrossRef Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22.CrossRef

go back to reference Aukes AM, et al. Long-term cerebral imaging after pre-eclampsia. BJOG. 2012;119:1117–22.CrossRef Aukes AM, et al. Long-term cerebral imaging after pre-eclampsia. BJOG. 2012;119:1117–22.CrossRef

go back to reference Robillard PY, Hulsey TC, Périanin J, Janky E, Miri EH, Papiernik E. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet. 1994;344, 347:619, 973–5. Robillard PY, Hulsey TC, Périanin J, Janky E, Miri EH, Papiernik E. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet. 1994;344, 347:619, 973–5.

go back to reference Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011;118:1102–7.CrossRef Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011;118:1102–7.CrossRef

go back to reference Postma IR, Slager S, Kremer HP, De Groot JC, Zeeman GG. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet Gynecol Surv. 2014;69:287–300.CrossRef Postma IR, Slager S, Kremer HP, De Groot JC, Zeeman GG. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet Gynecol Surv. 2014;69:287–300.CrossRef

go back to reference Koopmans CM, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.CrossRef Koopmans CM, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.CrossRef

go back to reference Willems D. Pre-eclampsia and long-term health. Obstet Med. 2012;5:98–104.CrossRef Willems D. Pre-eclampsia and long-term health. Obstet Med. 2012;5:98–104.CrossRef

go back to reference Nederlandse Vereniging voor Obstetrie en Gynaecologie. Addendum bij de multidisciplinaire richtlijn Hypertensieve aandoeningen in de zwangerschap uit 2011; 2014. Nederlandse Vereniging voor Obstetrie en Gynaecologie. Addendum bij de multidisciplinaire richtlijn Hypertensieve aandoeningen in de zwangerschap uit 2011; 2014.

go back to reference Giannubilo SR, Landi B, Ciavattini A. Preeclampsia: what could happen in a subsequent pregnancy? Obstet Gynecol Surv. 2014;69:747–62.CrossRef Giannubilo SR, Landi B, Ciavattini A. Preeclampsia: what could happen in a subsequent pregnancy? Obstet Gynecol Surv. 2014;69:747–62.CrossRef

go back to reference Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659.

go back to reference Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217:585.e1–5.CrossRef Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217:585.e1–5.CrossRef

go back to reference De Vries JI, Pampus MG, Van Hague WM, Bezemer PD, Joosten JH; FRUIT Investigators. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost. 2012;10:64–72. De Vries JI, Pampus MG, Van Hague WM, Bezemer PD, Joosten JH; FRUIT Investigators. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost. 2012;10:64–72.  

go back to reference Dodd JM, McLeod A, Windrim RC, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2013;(7):CD006780. Dodd JM, McLeod A, Windrim RC, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2013;(7):CD006780.

go back to reference Schaap TP, Van den Akker T, Zwart JJ, Van Roosmalen J, Bloemenkamp KWM. A national surveillance approach to monitor incidence of eclampsia: the Netherlands Obstetric Surveillance System (NethOSS). Acta Obstet Gynecol Scand. 2019;98;342–350.CrossRef Schaap TP, Van den Akker T, Zwart JJ, Van Roosmalen J, Bloemenkamp KWM. A national surveillance approach to monitor incidence of eclampsia: the Netherlands Obstetric Surveillance System (NethOSS). Acta Obstet Gynecol Scand. 2019;98;342–350.CrossRef

go back to reference https://www.ambulancezorg.nl/themas/kwaliteit-van-zorg/protocollen-en-richtlijnen/landelijk-protocol-ambulancezorg. https://​www.​ambulancezorg.​nl/​themas/​kwaliteit-van-zorg/​protocollen-en-richtlijnen/​landelijk-protocol-ambulancezorg.

go back to reference Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48:333–9.CrossRef Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48:333–9.CrossRef

go back to reference Anderson NH, Sadler LC, McKinley CJD, McCowan LME. Intergrowth-21st vs customized birth weight standards for identification of perinatal mortality and morbidity. Am J Obstet Gynecol. 2016;214(509):e1–7. Anderson NH, Sadler LC, McKinley CJD, McCowan LME. Intergrowth-21^st vs customized birth weight standards for identification of perinatal mortality and morbidity. Am J Obstet Gynecol. 2016;214(509):e1–7.

go back to reference Francis A, Hugh O, Gardosi J. Customized vs INTERGROWTH-21st standards for the assessment of birthweight and stillbirth risk at term. Am J Obstet Gynecol. 2018;218:S692–9.CrossRef Francis A, Hugh O, Gardosi J. Customized vs INTERGROWTH-21^st standards for the assessment of birthweight and stillbirth risk at term. Am J Obstet Gynecol. 2018;218:S692–9.CrossRef

go back to reference Chiossi G, Pedroza C, Costantine MM, Truong VTT, Gargano G, Saade GR. Customized vs population-based growth charts to identify neonates at risk of adverse outcome: systematic review and Bayesian meta-analysis of observational studies. Ultrasound Obstet Gynecol. 2017;50:156–66.CrossRef Chiossi G, Pedroza C, Costantine MM, Truong VTT, Gargano G, Saade GR. Customized vs population-based growth charts to identify neonates at risk of adverse outcome: systematic review and Bayesian meta-analysis of observational studies. Ultrasound Obstet Gynecol. 2017;50:156–66.CrossRef

go back to reference Lesmes C, Gallo DM, Panaiotova J, Poon LC, Nicolaides KH. Prediction of small-for-gestational-age neonates: screening by fetal biometry at 19–24 weeks. Ultrasound Obstet Gynecol. 2015;46:198–207.CrossRef Lesmes C, Gallo DM, Panaiotova J, Poon LC, Nicolaides KH. Prediction of small-for-gestational-age neonates: screening by fetal biometry at 19–24 weeks. Ultrasound Obstet Gynecol. 2015;46:198–207.CrossRef

go back to reference Bricker L, Medley N, Pratt JJ. Routine ultrasound in late pregnancy (after 24 weeks’ gestation). Cochrane Database Syst Rev. 2015 Jun 29;(6):CD001451. Bricker L, Medley N, Pratt JJ. Routine ultrasound in late pregnancy (after 24 weeks’ gestation). Cochrane Database Syst Rev. 2015 Jun 29;(6):CD001451.

go back to reference Robert Peter J, Ho JJ, Valliapan J, Sivasangari S. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth. Cochrane Database Syst Rev. 2015;(9):CD008136. Robert Peter J, Ho JJ, Valliapan J, Sivasangari S. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth. Cochrane Database Syst Rev. 2015;(9):CD008136.

go back to reference McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growthrestriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018;218:S855–68.CrossRef McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growthrestriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018;218:S855–68.CrossRef

go back to reference Temming LA, Dicke JM, Stout MJ, Rampersad RM, Macones GA, Tuuli MG, Cahill AG. Early second-trimester fetal growth restriction and adverse perinatal outcomes. Obstet Gynecol. 2017;130:865–9.CrossRef Temming LA, Dicke JM, Stout MJ, Rampersad RM, Macones GA, Tuuli MG, Cahill AG. Early second-trimester fetal growth restriction and adverse perinatal outcomes. Obstet Gynecol. 2017;130:865–9.CrossRef

go back to reference De Wit MC, Srebniak MI, Joosten M, Govaerts LC, Kornelisse RF, Papatsonis DN, De Graaff K, et al. Prenatal and postnatal findings in small-for-gestational-age fetuses without structural ultrasound anomalies at 18–24 weeks. Ultrasound Obstet Gynecol. 2017;49:342–8.CrossRef De Wit MC, Srebniak MI, Joosten M, Govaerts LC, Kornelisse RF, Papatsonis DN, De Graaff K, et al. Prenatal and postnatal findings in small-for-gestational-age fetuses without structural ultrasound anomalies at 18–24 weeks. Ultrasound Obstet Gynecol. 2017;49:342–8.CrossRef

go back to reference Boers KE, et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ. 2010;341:c7087.CrossRef Boers KE, et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ. 2010;341:c7087.CrossRef

go back to reference Matsson N, Rosendahl H, Luukkaala T. Good accuracy of ultrasound extimations of fetal weight performed by midwives. Acta Obstet Gynecol. 2007;86:688–92.CrossRef Matsson N, Rosendahl H, Luukkaala T. Good accuracy of ultrasound extimations of fetal weight performed by midwives. Acta Obstet Gynecol. 2007;86:688–92.CrossRef

go back to reference Sanchez-Ramos L, Bernstein S, Kaunitz AM. Expectant management versus labor induction for suspected fetal macrosomia: a systematic review. Obstet Gynecol. 2002;100:997–1002.CrossRef Sanchez-Ramos L, Bernstein S, Kaunitz AM. Expectant management versus labor induction for suspected fetal macrosomia: a systematic review. Obstet Gynecol. 2002;100:997–1002.CrossRef

go back to reference Boulvain M, Irion O, Dowswell T, Thornton JGInduction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev. 2016;5:CD000938. Boulvain M, Irion O, Dowswell T, Thornton JGInduction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev. 2016;5:CD000938.

go back to reference Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol. 1998;178:922–5.CrossRef Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol. 1998;178:922–5.CrossRef

go back to reference Muin DA, Haslacher H, Koller V, Kiss H, Scharrer A, Farr A. Impact of fetal maceration grade on risk of maternal disseminated intravascularcoagulation after intrauterine fetal death: a retrospective cohort study. Sci Rep. 2018;8:12742. Muin DA, Haslacher H, Koller V, Kiss H, Scharrer A, Farr A. Impact of fetal maceration grade on risk of maternal disseminated intravascularcoagulation after intrauterine fetal death: a retrospective cohort study. Sci Rep. 2018;8:12742.

go back to reference www.nvog.nl/wp-content/uploads/Begeleiding-bij-foetale-sterfte-en-doodgeboorte 1.0. www.​nvog.​nl/​wp-content/​uploads/​Begeleiding-bij-foetale-sterfte-en-doodgeboorte 1.0.

go back to reference www.nvog.nl/wp-content/uploads/Intra-uteriene-sterfte 1.0. www.​nvog.​nl/​wp-content/​uploads/​Intra-uteriene-sterfte 1.0.

go back to reference Tiemens-van Putten IKF, Lenderink HJ, Molkenboer JFM. Intacte preservatie van de jong overleen foetus. NTOG. 2015;128:403–5. Tiemens-van Putten IKF, Lenderink HJ, Molkenboer JFM. Intacte preservatie van de jong overleen foetus. NTOG. 2015;128:403–5.

go back to reference Wildschut HIJ, Van Goudoever JB, Den Hollander NS, Keirse E, De Wert G. Foetale en neonatale screening op aangeboren afwijkingen. Amsterdam: Reed Bussiness; 2011. Wildschut HIJ, Van Goudoever JB, Den Hollander NS, Keirse E, De Wert G. Foetale en neonatale screening op aangeboren afwijkingen. Amsterdam: Reed Bussiness; 2011.

go back to reference Gardner RJM, Amor DJ. Chromosome abnormalities and genetic counseling. 5th edition. Oxford University Press; 2018. Gardner RJM, Amor DJ. Chromosome abnormalities and genetic counseling. 5th edition. Oxford University Press; 2018. 

go back to reference Bijlsma EK, Oosterwijk JC, Leschot NJ, Geraedts JPM, Pronk JC. Leerboek medische genetica. 7e druk. Maarssen: Elsevier Gezondheidszorg; 2005. Bijlsma EK, Oosterwijk JC, Leschot NJ, Geraedts JPM, Pronk JC. Leerboek medische genetica. 7^e druk. Maarssen: Elsevier Gezondheidszorg; 2005. 

go back to reference https://www.huisartsengenetica.nl/info/stamboom-en-symbolen. https://​www.​huisartsengeneti​ca.​nl/​info/​stamboom-en-symbolen.

go back to reference Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, Howell LJ, et al.; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364:993–1004.CrossRef Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, Howell LJ, et al.; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364:993–1004.CrossRef

go back to reference Moldenhauer JS, Adzick NS. Fetal surgery for myelomeningocele: after the Management of Myelomeningocele Study (MOMS). Semin Fetal Neonatal Med. 2017;22:360–6.CrossRef Moldenhauer JS, Adzick NS. Fetal surgery for myelomeningocele: after the Management of Myelomeningocele Study (MOMS). Semin Fetal Neonatal Med. 2017;22:360–6.CrossRef

go back to reference De Keersmaecker B, Claus F, De Catte L. Imaging the fetal central nervous system. Facts Views Vis Obgyn. 2011;3:135–49.PubMedPubMedCentral De Keersmaecker B, Claus F, De Catte L. Imaging the fetal central nervous system. Facts Views Vis Obgyn. 2011;3:135–49.PubMedPubMedCentral

go back to reference Russo FM, De Coppi P, Allegaert K, Toelen J, Van der Veeken L, Attilakos G, Eastwood MP, et al. Current and future antenatal management of isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 2017;22:383–90.CrossRef Russo FM, De Coppi P, Allegaert K, Toelen J, Van der Veeken L, Attilakos G, Eastwood MP, et al. Current and future antenatal management of isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 2017;22:383–90.CrossRef

go back to reference Jansen FA, Hoffer MJ, Van Velzen CL, Plati SK, Rijlaarsdam ME, Clur SA, Blom NA, et al. Chromosomal abnormalities and copy number variations in fetal left-sidedcongenital heart defects. Prenat Diagn. 2016;36:177–85.CrossRef Jansen FA, Hoffer MJ, Van Velzen CL, Plati SK, Rijlaarsdam ME, Clur SA, Blom NA, et al. Chromosomal abnormalities and copy number variations in fetal left-sidedcongenital heart defects. Prenat Diagn. 2016;36:177–85.CrossRef

go back to reference Schrimmer DB, Moore TR. Sonographic evaluation of amniotic fluid. Clin Obstet Gynecol. 2002;45:1026–38.CrossRef Schrimmer DB, Moore TR. Sonographic evaluation of amniotic fluid. Clin Obstet Gynecol. 2002;45:1026–38.CrossRef

go back to reference Van der Heyden JL, Van der Ham DP, Van Kuijk S, Notten KJ, Janssen T, Nijhuis JG, Willekes C, et al. Outcome of pregnancies with preterm prelabor rupture of membranes before 27 weeks’ gestation: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;170:125–30. Van der Heyden JL, Van der Ham DP, Van Kuijk S, Notten KJ, Janssen T, Nijhuis JG, Willekes C, et al. Outcome of pregnancies with preterm prelabor rupture of membranes before 27 weeks’ gestation: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;170:125–30.

go back to reference Kömhoff M, Laghmani K. Pathophysiology of antenatal Bartter’s syndrome. Curr Opin Nephrol Hypertens. 2017;26:419–25.CrossRef Kömhoff M, Laghmani K. Pathophysiology of antenatal Bartter’s syndrome. Curr Opin Nephrol Hypertens. 2017;26:419–25.CrossRef

go back to reference Mercer BM, Goldenberg RL, Das AF, Thurnau GR, Bendon RW, Miodovnik M, Ramsey RD, Rabello YA; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. Semin Perinatol. 2003;27:217–30. Mercer BM, Goldenberg RL, Das AF, Thurnau GR, Bendon RW, Miodovnik M, Ramsey RD, Rabello YA; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. Semin Perinatol. 2003;27:217–30.

go back to reference Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2013;(12):CD000246. https://doi.org/10.1002/14651858.cd000246.pub2. Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2013;(12):CD000246. https://​doi.​org/​10.​1002/​14651858.​cd000246.​pub2.

go back to reference Quist-Nelson J, De Ruigh AA, Seidler AL, Van der Ham DP, Willekes C, Berghella V, Pajkrt E, et al.; Preterm Premature Rupture of Membranes Meta-analysis (PPROMM) Collaboration. Immediate delivery compared with expectant management in late preterm prelabor rupture of membranes: an individual participant data meta-analysis. Obstet Gynecol. 2018;131:269–79.CrossRef Quist-Nelson J, De Ruigh AA, Seidler AL, Van der Ham DP, Willekes C, Berghella V, Pajkrt E, et al.; Preterm Premature Rupture of Membranes Meta-analysis (PPROMM) Collaboration. Immediate delivery compared with expectant management in late preterm prelabor rupture of membranes: an individual participant data meta-analysis. Obstet Gynecol. 2018;131:269–79.CrossRef

go back to reference Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105:73–85, e1–6.CrossRef Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105:73–85, e1–6.CrossRef

go back to reference Hu HT, Xu JJ, Lin J, Li C, Wu YT, Sheng JZ, Liu XM, Huang HF. Association between first caesarean delivery and adverse outcomes in subsequentpregnancy: a retrospective cohort study. BMC Pregnancy Childbirth. 2018;18:273. Hu HT, Xu JJ, Lin J, Li C, Wu YT, Sheng JZ, Liu XM, Huang HF. Association between first caesarean delivery and adverse outcomes in subsequentpregnancy: a retrospective cohort study. BMC Pregnancy Childbirth. 2018;18:273.

go back to reference Gilliam M, Rosenberg D, Davis F. The likelihood of placenta previa with greater number of cesarean delivery and higher partity. Obstet Gynecol. 2002;99:976–80.PubMed Gilliam M, Rosenberg D, Davis F. The likelihood of placenta previa with greater number of cesarean delivery and higher partity. Obstet Gynecol. 2002;99:976–80.PubMed

go back to reference Schneider H, Moser RW. Classics revisited. Raissa Nitabuch, on the uteroplacental circulation and the fibrinous membrane. Placenta. 2016;40:34–9.CrossRef Schneider H, Moser RW. Classics revisited. Raissa Nitabuch, on the uteroplacental circulation and the fibrinous membrane. Placenta. 2016;40:34–9.CrossRef

go back to reference Cali G, Giambanco L, Puccio G Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from precreta. Ultrasound Obstet Gynecol. 2013;41:406–12.CrossRef Cali G, Giambanco L, Puccio G Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from precreta. Ultrasound Obstet Gynecol. 2013;41:406–12.CrossRef

go back to reference Riteau AS, Tassin M, Chambon G, Le Vaillant C, De Laveaucoupet J, Quéré MP, Joubert M, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. PLoS ONE. 2014;9:e94866.CrossRef Riteau AS, Tassin M, Chambon G, Le Vaillant C, De Laveaucoupet J, Quéré MP, Joubert M, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. PLoS ONE. 2014;9:e94866.CrossRef

go back to reference Fitzpatrick K, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;12:162–71. Fitzpatrick K, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;12:162–71.

go back to reference Ruiter L, Kok N, Limpens J, Derks JB, De Graaf IM, Mol BW, Pajkrt E. Systematic review of accuracy of ultrasound in the diagnosis of vasa previa. Ultrasound Obstet Gynecol. 2015;45:516–22.CrossRef Ruiter L, Kok N, Limpens J, Derks JB, De Graaf IM, Mol BW, Pajkrt E. Systematic review of accuracy of ultrasound in the diagnosis of vasa previa. Ultrasound Obstet Gynecol. 2015;45:516–22.CrossRef

go back to reference Van Sijl AM, et al. Vasa praevia als oorzaak van foetale verbloeding, een verrassing? Ned Tijdschr Obstet Gynaecol. 2009;122:13–6. Van Sijl AM, et al. Vasa praevia als oorzaak van foetale verbloeding, een verrassing? Ned Tijdschr Obstet Gynaecol. 2009;122:13–6.

go back to reference Warshauer E, Marcurio M. Update on dermatoses of pregnancy. Int J Dermatol. 2013;52:6–13.CrossRef Warshauer E, Marcurio M. Update on dermatoses of pregnancy. Int J Dermatol. 2013;52:6–13.CrossRef

go back to reference Sävervall C, Sand FL, Thomsen SF. Dermatological diseases associated with pregnancy: pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy, and atopic eruption of pregnancy. Dermatol Res Pract. 2015;2015:979635.CrossRef Sävervall C, Sand FL, Thomsen SF. Dermatological diseases associated with pregnancy: pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy, and atopic eruption of pregnancy. Dermatol Res Pract. 2015;2015:979635.CrossRef

go back to reference Sävervall C, Sand FL, Thomsen SF. Pemphigoid gestationis: current perspectives. Clin Cosmet Investig Dermatol. 2017;10:441–9.CrossRef Sävervall C, Sand FL, Thomsen SF. Pemphigoid gestationis: current perspectives. Clin Cosmet Investig Dermatol. 2017;10:441–9.CrossRef

go back to reference Genes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15:2049–66.CrossRef Genes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15:2049–66.CrossRef

go back to reference Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar A, Kebapcilar L, Kondrackienė J, Koster MPH(17), Kowalska-Kańka A(18), Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393: 899–909. Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar A, Kebapcilar L, Kondrackienė J, Koster MPH(17), Kowalska-Kańka A(18), Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393: 899–909.

go back to reference Steele RB, Nugent WH, Braswell SF, Frisch S, Ferrell J, Ortega-Loayza AG. Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and hallenging treatment. Br J Dermatol. 2016;174:77–87.CrossRef Steele RB, Nugent WH, Braswell SF, Frisch S, Ferrell J, Ortega-Loayza AG. Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and hallenging treatment. Br J Dermatol. 2016;174:77–87.CrossRef